Literature DB >> 31714794

Challenges and Strengths of Multidisciplinary Research in Audiology: The EVOTION Example.

Giorgos Dritsakis1, Louisa Murdin2, Dimitris Kikidis3, Gabrielle H Saunders4, Panagiotis Katrakazas5, Dario Brdarić6, Katherine Ploumidou7, Doris-Eva Bamiou1,8.   

Abstract

Purpose The EU-funded research project EVOTION has brought together clinical, technical, and public health experts with the aim to offer a solution for the holistic management of hearing loss. This report presents the challenges, strengths, and key take-home messages of working in this multidisciplinary consortium. Method Fifteen consortium members completed an online survey with 6 open-ended questions. Responses were analyzed using a thematic approach. Results Analysis identified 4 main themes: (a) communication, that is, cross-disciplinary communication difficulties but also range of expertise; (b) opportunities, that is, innovation, learning, and collaborations; (c) technology, that is, technical requirements and data collection and management issues; and (d) local constraints, that is, institutional limitations, resources, and planning. Conclusions Although the challenges reported differed by country and specialty, there was consensus about the value, expertise, and opportunities of the project. It is recommended that in future similar multidisciplinary projects in audiology, researchers establish a common language and assess technical requirements and local constraints prior to initiating research activities.

Entities:  

Mesh:

Year:  2019        PMID: 31714794     DOI: 10.1044/2019_AJA-19-0034

Source DB:  PubMed          Journal:  Am J Audiol        ISSN: 1059-0889            Impact factor:   1.493


  1 in total

1.  Public health policy-making for hearing loss: stakeholders' evaluation of a novel eHealth tool.

Authors:  Giorgos Dritsakis; Lyubov Trenkova; Mariola Śliwińska-Kowalska; Dario Brdarić; Niels Henrik Pontoppidan; Panagiotis Katrakazas; Doris-Eva Bamiou
Journal:  Health Res Policy Syst       Date:  2020-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.